208 related articles for article (PubMed ID: 37458037)
1. Cerebrovascular miRNAs Track Early Development of Alzheimer's Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation.
Chum PP; Bishara MA; Solis SR; Behringer EJ
J Alzheimers Dis; 2024; 99(s2):S187-S234. PubMed ID: 37458037
[TBL] [Abstract][Full Text] [Related]
2. Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer's Disease in a Mouse Model.
Chum PP; Hakim MA; Behringer EJ
J Alzheimers Dis; 2022; 85(1):91-113. PubMed ID: 34776451
[TBL] [Abstract][Full Text] [Related]
3. Cerebrovascular miRNAs correlate with the clearance of Aβ through perivascular route in younger 3xTg-AD mice.
Fu L; Jiang G; Weng H; Dick GM; Chang Y; Kassab GS
Brain Pathol; 2020 Jan; 30(1):92-105. PubMed ID: 31206909
[TBL] [Abstract][Full Text] [Related]
4. Profiling microRNA from Brain by Microarray in a Transgenic Mouse Model of Alzheimer's Disease.
Wang LL; Min L; Guo QD; Zhang JX; Jiang HL; Shao S; Xing JG; Yin LL; Liu JH; Liu R; Guo SL
Biomed Res Int; 2017; 2017():8030369. PubMed ID: 29057267
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression analysis of adult-onset Drosophila Alzheimer's disease model.
Kong Y; Wu J; Yuan L
Curr Alzheimer Res; 2014; 11(9):882-91. PubMed ID: 25274109
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.
Kumar S; Vijayan M; Reddy PH
Hum Mol Genet; 2017 Oct; 26(19):3808-3822. PubMed ID: 28934394
[TBL] [Abstract][Full Text] [Related]
7. Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology.
Sierksma A; Lu A; Salta E; Vanden Eynden E; Callaerts-Vegh Z; D'Hooge R; Blum D; Buée L; Fiers M; De Strooper B
Mol Neurodegener; 2018 Oct; 13(1):54. PubMed ID: 30314521
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression data analysis to identify key miRNAs associated with Alzheimer's disease.
Chen J; Qi Y; Liu CF; Lu JM; Shi J; Shi Y
J Gene Med; 2018 Jun; 20(6):e3014. PubMed ID: 29543360
[TBL] [Abstract][Full Text] [Related]
9. miRNA-27a-3p and miRNA-222-3p as Novel Modulators of Phosphodiesterase 3a (PDE3A) in Cerebral Microvascular Endothelial Cells.
Yasmeen S; Kaur S; Mirza AH; Brodin B; Pociot F; Kruuse C
Mol Neurobiol; 2019 Aug; 56(8):5304-5314. PubMed ID: 30603956
[TBL] [Abstract][Full Text] [Related]
10. Unique miRomics Expression Profiles in
Aravindraja C; Jeepipalli S; Duncan W; Vekariya KM; Bahadekar S; Chan EKL; Kesavalu L
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003583
[No Abstract] [Full Text] [Related]
11. miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer's disease.
Han SW; Pyun JM; Bice PJ; Bennett DA; Saykin AJ; Kim SY; Park YH; Nho K
Alzheimers Res Ther; 2024 Jan; 16(1):5. PubMed ID: 38195609
[TBL] [Abstract][Full Text] [Related]
12. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.
Wang D; Fei Z; Luo S; Wang H
Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.
Braza-Boïls A; Salloum-Asfar S; Marí-Alexandre J; Arroyo AB; González-Conejero R; Barceló-Molina M; García-Oms J; Vicente V; Estellés A; Gilabert-Estellés J; Martínez C
Hum Reprod; 2015 Oct; 30(10):2292-302. PubMed ID: 26307093
[TBL] [Abstract][Full Text] [Related]
14. miR-124 regulates cerebromicrovascular function in APP/PS1 transgenic mice via C1ql3.
Li AD; Tong L; Xu N; Ye Y; Nie PY; Wang ZY; Ji LL
Brain Res Bull; 2019 Nov; 153():214-222. PubMed ID: 31499089
[TBL] [Abstract][Full Text] [Related]
15. RNA and Oxidative Stress in Alzheimer's Disease: Focus on microRNAs.
Nunomura A; Perry G
Oxid Med Cell Longev; 2020; 2020():2638130. PubMed ID: 33312335
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of endothelial colony-forming cell function by a negative feedback loop of circulating miR-146a and -146b in cardiovascular disease patients.
Chang TY; Tsai WC; Huang TS; Su SH; Chang CY; Ma HY; Wu CH; Yang CY; Lin CH; Huang PH; Cheng CC; Cheng SM; Wang HW
PLoS One; 2017; 12(7):e0181562. PubMed ID: 28727754
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer's disease by enhancing autophagy.
Chen ML; Hong CG; Yue T; Li HM; Duan R; Hu WB; Cao J; Wang ZX; Chen CY; Hu XK; Wu B; Liu HM; Tan YJ; Liu JH; Luo ZW; Zhang Y; Rao SS; Luo MJ; Yin H; Wang YY; Xia K; Tang SY; Xie H; Liu ZZ
Theranostics; 2021; 11(5):2395-2409. PubMed ID: 33500732
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer's disease.
Dakterzada F; Targa A; Benítez ID; Romero-ElKhayat L; de Gonzalo-Calvo D; Torres G; Moncusí-Moix A; Huerto R; Sánchez-de-la-Torre M; Barbé F; Piñol-Ripoll G
Alzheimers Res Ther; 2020 Dec; 12(1):163. PubMed ID: 33278902
[TBL] [Abstract][Full Text] [Related]
19. Exercise-mediated alteration of hippocampal Dicer mRNA and miRNAs is associated with lower BACE1 gene expression and Aβ
Dungan CM; Valentino T; Vechetti IJ; Zdunek CJ; Murphy MP; Lin AL; McCarthy JJ; Peterson CA
J Neurophysiol; 2020 Dec; 124(6):1571-1577. PubMed ID: 33052800
[TBL] [Abstract][Full Text] [Related]
20. Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases.
Barbagallo C; Mostile G; Baglieri G; Giunta F; Luca A; Raciti L; Zappia M; Purrello M; Ragusa M; Nicoletti A
Cell Mol Neurobiol; 2020 May; 40(4):531-546. PubMed ID: 31691877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
